MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

28 Jul 2016 Evaluate

Sun Pharmaceutical Industries has informed about a Press Release dated July 27, 2016 titled ‘Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..